Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6051
ESCO Technologies
ESE
$8.24B
| $50K | ﹤0.01% |
1,477
-12,004
| -89% | -$413K |
|
6052
CALL
Gerdau
GGB
$9.93B
| $50K | ﹤0.01% |
9,072
-27,846
| -75% | -$174K |
|
6053
PUT
Invesco
IVZ
$13.6B
| $50K | ﹤0.01% |
1,400
-18,000
| -93% | -$611K |
|
6054
Middlesex Water
MSEX
$1.07B
| $50K | ﹤0.01% |
2,488
+1,313
| +112% | +$27.8K |
|
6055
Qualys
QLYS
$5.45B
| $50K | ﹤0.01% |
2,148
-682
| -24% | -$15.2K |
|
|
KOL
6056
DELISTED
VanEck Vectors Coal ETF
KOL
| $50K | ﹤0.01% |
262
-129
| -33% | -$25.5K |
|
|
MXWL
6057
DELISTED
Maxwell Technologies Inc
MXWL
| $50K | ﹤0.01% |
6,921
+5,748
| +490% | +$44.8K |
|
|
CXA
6058
DELISTED
SPDR NUVEEN BARCLAYS CALIF MUN BD ETF
CXA
| $50K | ﹤0.01% |
2,365
-5,615
| -70% | -$128K |
|
|
RNA
6059
CALL
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $50K | ﹤0.01% |
+12,600
| New | +$57.4K |
|
6060
Aaon
AAON
$7.58B
| $49K | ﹤0.01% |
3,535
-32,098
| -90% | -$407K |
|
6061
Consolidated Water Co
CWCO
$473M
| $49K | ﹤0.01% |
+3,458
| New | +$48.8K |
|
|
DOG
6062
CALL
ProShares Short Dow30
DOG
$98.9M
| $49K | ﹤0.01% |
475
+425
| +850% | +$47K |
|
6063
CALL
iShares MSCI Canada ETF
EWC
$6.16B
| $49K | ﹤0.01% |
1,700
-33,000
| -95% | -$955K |
|
6064
CALL
First Trust Natural Gas ETF
FCG
$638M
| $49K | ﹤0.01% |
520
-2,240
| -81% | -$218K |
|
6065
Franklin Electric
FELE
$4.73B
| $49K | ﹤0.01% |
1,127
-19,099
| -94% | -$780K |
|
6066
CALL
Helen of Troy
HELE
$676M
| $49K | ﹤0.01% |
1,000
+800
| +400% | +$37.5K |
|
6067
CALL
Lindsay Corp
LNN
$1.15B
| $49K | ﹤0.01% |
600
-1,900
| -76% | -$148K |
|
6068
PUT
Medifast
MED
$108M
| $49K | ﹤0.01% |
1,900
-15,400
| -89% | -$395K |
|
6069
TriCo Bancshares
TCBK
$1.85B
| $49K | ﹤0.01% |
1,739
-671
| -28% | -$17.3K |
|
6070
Vanguard FTSE Pacific ETF
VPL
$8.13B
| $49K | ﹤0.01% |
780
-216
| -22% | -$13.2K |
|
|
WX
6071
CALL
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $49K | ﹤0.01% |
1,300
-4,200
| -76% | -$133K |
|
|
EBIX
6072
DELISTED
Ebix Inc
EBIX
| $49K | ﹤0.01% |
3,472
-49,909
| -93% | -$641K |
|
6073
8x8 Inc
EGHT
$292M
| $48K | ﹤0.01% |
4,787
-12,915
| -73% | -$132K |
|
6074
CALL
ProShares UltraShort FTSE Europe
EPV
$10.9M
| $48K | ﹤0.01% |
160
-265
| -62% | -$88.8K |
|
6075
German American Bancorp
GABC
$1.92B
| $48K | ﹤0.01% |
2,561
+1,356
| +113% | +$24.5K |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.88B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.